[go: up one dir, main page]

Giuliani et al., 2017 - Google Patents

Mitochondrial (Dys) function in inflammaging: do MitomiRs influence the energetic, oxidative, and inflammatory status of senescent cells?

Giuliani et al., 2017

View PDF @Full View
Document ID
4201812251808431124
Author
Giuliani A
Prattichizzo F
Micolucci L
Ceriello A
Procopio A
Rippo M
Publication year
Publication venue
Mediators of inflammation

External Links

Snippet

A relevant feature of aging is chronic low‐grade inflammation, termed inflammaging, a key process promoting the development of all major age‐related diseases. Senescent cells can acquire the senescence‐associated (SA) secretory phenotype (SASP), characterized by the …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides

Similar Documents

Publication Publication Date Title
Giuliani et al. Mitochondrial (Dys) function in inflammaging: do MitomiRs influence the energetic, oxidative, and inflammatory status of senescent cells?
Bhatti et al. Emerging role of non‐coding RNA in health and disease
Gruber et al. HAT1 coordinates histone production and acetylation via H4 promoter binding
Akira et al. Control of RNA stability in immunity
Lucas et al. RNA therapeutics in cardiovascular disease
Briata et al. Diverse roles of the nucleic acid‐binding protein KHSRP in cell differentiation and disease
Valinezhad Orang et al. Mechanisms of miRNA‐mediated gene regulation from common downregulation to mRNA‐specific upregulation
Ma et al. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation
Haneklaus et al. miR‐223: infection, inflammation and cancer
Park et al. MicroRNA‐127‐5p regulates matrix metalloproteinase 13 expression and interleukin‐1β–induced catabolic effects in human chondrocytes
Li et al. Control of mitochondrial activity by miRNAs
Matsumoto et al. MiR-29a assists in preventing the activation of human stellate cells and promotes recovery from liver fibrosis in mice
Kalla et al. MicroRNAs: new players in IBD
Zhao et al. MicroRNAs play an essential role in autophagy regulation in various disease phenotypes
Miniarikova et al. Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington's disease
Abdelmohsen et al. RNA-binding protein nucleolin in disease
Duarte et al. The emerging role of MitomiRs in the pathophysiology of human disease
Olive et al. Outside the coding genome, mammalian microRNAs confer structural and functional complexity
Yuan et al. MiR‐590‐3p regulates proliferation, migration and collagen synthesis of cardiac fibroblast by targeting ZEB1
Yang et al. Transfer RNA-derived small RNAs in tumor microenvironment
Fortunato et al. Therapeutic use of microRNAs in lung cancer
Singh et al. Tiny regulators of massive tissue: MicroRNAs in skeletal muscle development, myopathies, and cancer cachexia
Andreeva et al. MicroRNAs in the neural retina
Yang et al. miR‐193b represses influenza A virus infection by inhibiting Wnt/β‐catenin signalling
Valentino et al. Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load‐induced hypertrophy